U.S. Markets closed

Albany Molecular Research, Inc. (AYM.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
19.035-0.00 (-0.02%)
At close: 1:28PM CEST
Full screen
Previous Close19.039
Bid19.279 x 26300
Ask19.451 x 25300
Day's Range19.035 - 19.035
52 Week Range11.708 - 19.473
Avg. Volume14
Market Cap844.86M
PE Ratio (TTM)-10.82
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters18 days ago

    GTCR, Carlyle to buy contract research firm Albany Molecular

    Contract drug manufacturer and research company Albany Molecular Research Inc said on Tuesday it had agreed to be taken private by buyout firms Carlyle Group LP and GTCR LLC for about $922 million in cash. Clinical research organizations can prove to be lucrative investments for private equity firms.

  • The Wall Street Journal18 days ago

    [$$] Carlyle, GTCR to Acquire Contract-Drug Manufacturer

    Contract-drug manufacturer Albany Molecular Research Inc. said Tuesday that it has agreed to be acquired by private-equity firms Carlyle Group LP and GTCR LLC in a deal worth about $933.9 million.

  • 24/7 Wall St.18 days ago

    Why Albany Molecular Is Actually Getting a Very Good Premium

    Shares of Albany Molecular Research saw a handy gain on Tuesday after it was announced that the company signed a definitive agreement to be acquired.